Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cambio Provides Microzone PCR and DNA Reagents to Life Science Market

Published: Thursday, April 25, 2013
Last Updated: Thursday, April 25, 2013
Bookmark and Share
Cambio supplies Microzone’s MegaMix, microLYSIS® and MicroCLEAN products.

Cambio is able to supply its customers with a selection of reagents by Microzone. MegaMix, microLYSIS® and MicroCLEAN are each specifically designed as convenient and efficient solutions for PCR, DNA release and DNA clean-up respectively.

By incorporating these reagents into their procedures, life scientists can save time that would otherwise be spent creating their own mixes, as well as reducing risk of contamination.

Thanks to their standardized formulation, the Microzone reagents also dramatically increase the reproducibility of DNA amplification, giving researchers the upmost confidence in their methods, and therefore their results.

MegaMix is a PCR master mix containing all the fixed components needed for PCR amplification, including an enzyme cocktail consisting of two Taq polymerases, dNTPs, MgCl2, reaction buffers and enzyme stabilizers.

All these components are optimized to maximize yield with minimal non-specific background and the product is exceptionally easy to use - the MegaMix just has to be thawed, the recommended volume drawn and DNA and primers added.

MegaMix can survive multiple freeze/thaw cycles without deterioration of either product or function.

MegaMix is also available with dye to allow easy visualization, and double concentrated for added convenience.

In addition, Cambio also supplies Microzone’s MicroCLEAN and microLYSIS® products. MicroCLEAN is a rapid, one tube, one and half spin DNA reagent which cleans up any double stranded DNA from reaction buffers, enzymes, primers or dNTPs.

The versatile reagent has no limit on the size or volume of the target DNA and requires no additional manipulation, such as phenol extractions or spin columns.

Finally, microLYSIS® and microLYSIS®-Plus are novel reagents designed for use as a pre-step to PCR. When combined with rapid heating and cooling of thermocyclers, the unique mycroLYSIS® formulation effectively lyses the cells and enables users to reach the PCR stage in less than 15 minutes.

For tougher cell samples, such as those found in plant and some animal tissues, microLYSIS®-Plus can still offer the same impressive results.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!